Published in Cancer Weekly, March 10th, 1997
The authors examined this relationship because it is difficult to measure a woman's estrogen level over her lifetime and bone mass measurement might be a useful way to determine estrogen exposure, and therefore, predict who is at greatest risk for breast cancer. According to the National Osteoporosis Foundation, while this is an important study, more research is needed to understand why postmenopausal women with breast cancer have higher bone mass.
"There are many factors that influence...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.